-
Je něco špatně v tomto záznamu ?
Medicinal Use of Testosterone and Related Steroids Revisited
J. Tauchen, M. Jurášek, L. Huml, S. Rimpelová
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články, přehledy
Grantová podpora
No. CZ.02.1.01/0.0/0.0/16_019/0000845
European Regional Development Fund - Project
A1_FPBT_2020_004
The Institutional Plan of the UCT Prague
NLK
Directory of Open Access Journals
od 1997
Free Medical Journals
od 1997
PubMed Central
od 2001
Europe PubMed Central
od 2001
ProQuest Central
od 1997-01-01
Open Access Digital Library
od 1997-01-01
Medline Complete (EBSCOhost)
od 2009-03-01
Health & Medicine (ProQuest)
od 1997-01-01
- MeSH
- lidé MeSH
- nové syntetické drogy chemie terapeutické užití MeSH
- prekurzory léčiv chemie terapeutické užití MeSH
- rostliny chemie MeSH
- steroidy chemie terapeutické užití MeSH
- testosteron agonisté analogy a deriváty chemie terapeutické užití MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Testosterone derivatives and related compounds (such as anabolic-androgenic steroids-AAS) are frequently misused by athletes (both professional and amateur) wishing to promote muscle development and strength or to cover AAS misuse. Even though these agents are vastly regarded as abusive material, they have important pharmacological activities that cannot be easily replaced by other drugs and have therapeutic potential in a range of conditions (e.g., wasting syndromes, severe burns, muscle and bone injuries, anemia, hereditary angioedema). Testosterone and related steroids have been in some countries treated as controlled substances, which may affect the availability of these agents for patients who need them for therapeutic reasons in a given country. Although these agents are currently regarded as rather older generation drugs and their use may lead to serious side-effects, they still have medicinal value as androgenic, anabolic, and even anti-androgenic agents. This review summarizes and revisits the medicinal use of compounds based on the structure and biological activity of testosterone, with examples of specific compounds. Additionally, some of the newer androgenic-anabolic compounds are discussed such as selective androgen receptor modulators, the efficacy/adverse-effect profiles of which have not been sufficiently established and which may pose a greater risk than conventional androgenic-anabolic agents.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21019245
- 003
- CZ-PrNML
- 005
- 20210830100825.0
- 007
- ta
- 008
- 210728s2021 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/molecules26041032 $2 doi
- 035 __
- $a (PubMed)33672087
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Tauchen, Jan $u Department of Food Science, Faculty of Agrobiology, Food, and Natural Resources, Czech University of Life Sciences Prague, Kamýcká 129, 165 00 Prague-Suchdol, Czech Republic
- 245 10
- $a Medicinal Use of Testosterone and Related Steroids Revisited / $c J. Tauchen, M. Jurášek, L. Huml, S. Rimpelová
- 520 9_
- $a Testosterone derivatives and related compounds (such as anabolic-androgenic steroids-AAS) are frequently misused by athletes (both professional and amateur) wishing to promote muscle development and strength or to cover AAS misuse. Even though these agents are vastly regarded as abusive material, they have important pharmacological activities that cannot be easily replaced by other drugs and have therapeutic potential in a range of conditions (e.g., wasting syndromes, severe burns, muscle and bone injuries, anemia, hereditary angioedema). Testosterone and related steroids have been in some countries treated as controlled substances, which may affect the availability of these agents for patients who need them for therapeutic reasons in a given country. Although these agents are currently regarded as rather older generation drugs and their use may lead to serious side-effects, they still have medicinal value as androgenic, anabolic, and even anti-androgenic agents. This review summarizes and revisits the medicinal use of compounds based on the structure and biological activity of testosterone, with examples of specific compounds. Additionally, some of the newer androgenic-anabolic compounds are discussed such as selective androgen receptor modulators, the efficacy/adverse-effect profiles of which have not been sufficiently established and which may pose a greater risk than conventional androgenic-anabolic agents.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a nové syntetické drogy $x chemie $x terapeutické užití $7 D015198
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a rostliny $x chemie $7 D010944
- 650 _2
- $a prekurzory léčiv $x chemie $x terapeutické užití $7 D011355
- 650 _2
- $a steroidy $x chemie $x terapeutické užití $7 D013256
- 650 _2
- $a testosteron $x agonisté $x analogy a deriváty $x chemie $x terapeutické užití $7 D013739
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Jurášek, Michal $u Department of Chemistry of Natural Compounds, University of Chemistry and Technology Prague, Technická 5, Prague 6, 166 28 Prague, Czech Republic
- 700 1_
- $a Huml, Lukáš $u Department of Chemistry of Natural Compounds, University of Chemistry and Technology Prague, Technická 5, Prague 6, 166 28 Prague, Czech Republic
- 700 1_
- $a Rimpelová, Silvie $u Department of Biochemistry and Microbiology, University of Chemistry and Technology Prague, Technická 5, Prague 6, 166 28 Prague, Czech Republic
- 773 0_
- $w MED00180394 $t Molecules (Basel, Switzerland) $x 1420-3049 $g Roč. 26, č. 4 (2021)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33672087 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210728 $b ABA008
- 991 __
- $a 20210830100825 $b ABA008
- 999 __
- $a ok $b bmc $g 1690139 $s 1139691
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 26 $c 4 $e 20210215 $i 1420-3049 $m Molecules $n Molecules $x MED00180394
- GRA __
- $a No. CZ.02.1.01/0.0/0.0/16_019/0000845 $p European Regional Development Fund - Project
- GRA __
- $a A1_FPBT_2020_004 $p The Institutional Plan of the UCT Prague
- LZP __
- $a Pubmed-20210728